SmartSkin unveils seal assurance technology to boost pharma container integrity

CANADA — SmartSkin Technologies, a Canadian leader in manufacturing intelligence, has launched SmartSkin Seal Assurance, a new solution designed to provide pharmaceutical companies with real-time insights into seal tightness on vials and cartridges.

The innovation aims to strengthen container closure integrity (CCI), a critical aspect of pharmaceutical safety and quality.

The technology will make its official debut at the 2025 ISPE Pharma 4.0 trade show in Barcelona, Spain, on December 9–10, where SmartSkin will showcase its capabilities to a global audience.

“Despite the critical importance of seal quality for sterile products, translating the mechanical settings of capping equipment into the physical seal characteristics needed for container-closure performance has not been possible until now,” said Dr. Mihaela Simianu, scientific advisor at SmartSkin.

She added that Seal Assurance enables manufacturers to proactively embed CCI assurance into aseptic process design, creating measurable and controllable improvements in equipment and process performance.

The system provides per-head, real-time feedback on sealing performance, measuring and visualizing the forces applied during capping.

Each sealing event generates a digital signature, serving as auditable proof that every capper head operates within specification.

According to SmartSkin, this feature helps confirm the quality and consistency of pharmaceutical products during setup and production.

Compatible with both single and multihead capping systems, SmartSkin Seal Assurance is designed to complement Residual Seal Force (RSF) testing, ensuring that optimal sealing conditions are achieved from the start.

Early testing by SmartSeal, one of the world’s largest pharmaceutical manufacturers, reportedly demonstrated the system’s ability to detect inconsistencies and identify ideal capping parameters, validating its role in enhancing production quality and efficiency.

The launch aligns with broader industry trends emphasizing digitalization and real-time monitoring in pharmaceutical manufacturing.

According to ISPE experts, technologies like SmartSkin Seal Assurance support regulatory compliance while reducing the risk of defective products reaching the market.

This announcement follows recent innovations in pharmaceutical packaging, such as BD’s intelligent syringe platforms and SCHOTT’s digital vial inspection systems, which similarly focus on monitoring and verifying container integrity to meet increasingly stringent safety standards.

With rising global demand for biologics and sterile injectables, SmartSkin Seal Assurance positions the company at the forefront of next-generation pharma packaging solutions, promising manufacturers both operational efficiency and enhanced patient safety.

Subscribe to our email newsletters that provide busy executives like you with the latest news insights and trends from Africa and the World. SUBSCRIBE HERE